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Abstract
Podosomes are cellular structures acting as degradation ‘hot-spots’ in monocytic cells. They appear as dot-like structures at
the ventral cell surface, enriched in F-actin and actin regulators, including gelsolin and L-plastin. Gelsolin is an ubiquitous
severing and capping protein, whereas L-plastin is a leukocyte-specific actin bundling protein. The presence of the capping
protein CapG in podosomes has not yet been investigated. We used an innovative approach to investigate the role of these
proteins in macrophage podosomes by means of nanobodies or Camelid single domain antibodies. Nanobodies directed
against distinct domains of gelsolin, L-plastin or CapG were stably expressed in macrophage-like THP-1 cells. CapG was not
enriched in podosomes. Gelsolin nanobodies had no effect on podosome formation or function but proved very effective in
tracing distinct gelsolin populations. One gelsolin nanobody specifically targets actin-bound gelsolin and was effectively
enriched in podosomes. A gelsolin nanobody that blocks gelsolin-G-actin interaction was not enriched in podosomes
demonstrating that the calcium-activated and actin-bound conformation of gelsolin is a constituent of podosomes. THP-1
cells expressing inhibitory L-plastin nanobodies were hampered in their ability to form stable podosomes. Nanobodies did
not perturb Ser5 phosphorylation of L-plastin although phosphorylated L-plastin was highly enriched in podosomes.
Furthermore, nanobody-induced inhibition of L-plastin function gave rise to an irregular and unstable actin turnover of
podosomes, resulting in diminished degradation of the underlying matrix. Altogether these results indicate that L-plastin is
indispensable for podosome formation and function in macrophages.
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Introduction
Podosomes are cellular structures which establish close contact
with the extracellular matrix. They were discovered in monocytic
cells such as macrophages, dendritic cells and osteoclasts [1–3].
More recently, other cell types such as endothelial cells and
smooth muscle cells have been shown to form podosomes upon
stimulation with cytokines [4,5] or phorbol esters [6,7]. Similar
structures are found in cancer cells, termed ‘invadopodia’ [8].
Usually situated at the periphery of the cellular membrane,
podosomes display a polarized distribution pattern in migrating
cells, located between the lamellipodium and lamellum [9]. Their
primary purpose is connected to cellular motility, matrix
remodeling and tissue invasion. Therefore, they are highly
dynamic structures and are mainly found in motile cells that have
to cross tissue boundaries [10]. Podosomes are physiologically
relevant structures, as impairment of podosome formation leads to
a number of symptoms and diseases. A most notable example is
the Wiskott-Aldrich syndrome (WAS), arising due to mutations in
the gene encoding WASP (important in podosome formation), and
characterized by immune defects, eczema and lymphoma [11].
Podosomes present as dot-like structures (0.5–2 mm diameter) at
the ventral cell surface, and consist of a central ‘core’ rich in tightly
packed actin bundles, surrounded by a ring of adhesion, signaling
and scaffolding proteins including, among others, integrins, talin,
paxillin and vinculin. The actin core is connected to the ring
domain by an array of radial actin fibers, which ancor the core
bundle to the ring [12]. The core bundle of podosomes is enriched
in several actin-associated proteins, such as Arp2/3, cortactin,
WIP, WASP, dynamin and gelsolin [10]. The filaments within
these structures are highly regulated by actin nucleators, cross-
linking proteins, kinases and small GTPases. Consequently, total
actin turnover occurs within seconds [2].
This study focuses on 3 well-known actin binding proteins: L-
plastin, gelsolin and CapG. L-plastin or ‘‘leukocyte-plastin’’ (LPL)
occurs predominantly in hematopoietic cells, but ectopic expres-
sion is also observed in cancer cells [13,14]. Bundling proteins like
L-plastin bind 2 actin filaments and cross-link them into tight
bundles. LPL is composed of 2 N-terminal EF-hands, involved in
calcium binding, followed by 2 actin binding domains (ABDs). Its
F-actin binding and bundling activities are negatively regulated by
calcium [15]. L-plastin contains two N-terminal phosphorylation
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sites: Ser5 (predominant site) and Ser7. Phosphorylation enhances
targeting of LPL to F-actin rich structures and increases its actin
bundling activity [16]. Gelsolin and CapG are members of the
gelsolin superfamily. Gelsolin consists of 6 homologous structural
domains, whereas CapG has only 3 such domains [17]. They are
both widely expressed in mammalian cells, including hematopoi-
etic cells such as neutrophils and macrophages [18–21]. Gelsolin
severs F-actin after which it remains attached to the barbed end of
the filament as a cap, preventing further actin polymerization.
CapG shares this capping function with gelsolin, but lacks its
severing function [22,23]. They are both activated by calcium and
negatively regulated by phosphoinositides, and both are involved
in organizing cell structure, motility and invasion [21,24–28].
L-plastin and gelsolin (GSN) have both been shown to reside in
podosomes. L-plastin function in podosomes has not been fully
elucidated yet, but it probably plays a role during early stages of
cell adhesion and spreading. The presence of gelsolin in
podosomes has been well documented [29–31]. In GSN2/2
osteoclasts the formation and degradative activity of podosomes is
impaired [30], whereas in dendritic cells, gelsolin deficiency does
not affect podosome formation and function [32]. The presence of
CapG in podosomes has not been investigated yet.
Nanobodies correspond with the antigen-binding domains of
‘‘heavy-chain only antibodies’’, which are found in Camelidae
species and cartilaginous fish such as sharks [33,34]. They are only
15 kDa in size and can be easily cloned. Nanobodies generally
bind their target with nanomolar affinity and have been used in a
number of applications: neutralization of toxins [35], as a
crystallization aid [36], inactivation of viral proteins [37], or
blocking selected functions of cytoskeletal proteins in the
cytoplasm [38–40].
In this study we used bona fide nanobodies against L-plastin,
gelsolin and CapG as intrabodies to investigate if, and to what
extent, these functionally distinct proteins contribute to podosome
function and integrity. The majority of nanobodies that were used
inhibit biochemical activities of their target, resulting in a protein
domain ‘knock-out’, without affecting their expression level in
cells. We report that expression of L-plastin nanobodies in
macrophage-like THP-1 cells perturbs podosome formation and
stability, as evidenced by a higher turn-over, and concurrent
shorter lifetime, of podosomes. In addition, blocking L-plastin
bundling or locking L-plastin in an inactive conformation reduces
the ability of these cells to degrade the extracellular matrix. We
further demonstrate that phosphorylated L-plastin is highly
enriched in podosomes, underscoring the importance of its actin
bundling properties in podosome stability. Gelsolin and CapG
nanobodies on the other hand, did not significantly affect
podosome formation or matrix degradation. Hence, L-plastin is
an integral and functional constituent of macrophage podosomes.
Results
Unlike CapG, L-plastin and gelsolin localize in podosomes
of macrophage-differentiated THP-1 cells
The composition and assembly of podosomes have been under
extensive research (reviewed in [10,31,41]). Several actin binding
proteins are present in podosomes, but for some, their exact
functions have not been elucidated. Nanobodies targeting
functional regions of such proteins with nanomolar affinity serve
as a tool to investigate protein function(s) in distinct cellular
contexts, as demonstrated before [38–40] (Van Impe et al,
unpublished data). The presence of CapG in podosomes has not
been investigated yet, but L-plastin and gelsolin were shown to
reside in podosomes (reviewed in [10,31,41,42]). We set out to
employ nanobodies against these constituents in the podosome
assembly process in macrophage-like THP-1 cells.
THP-1 cells, a human monocytic leukemia cell line, are one of
the most widely used models to study the monocytic differentiation
process and biological functions of differentiated cells [43,44].
They grow in suspension but can be easily differentiated into
adherent macrophage-like cells by treatment with compounds
such as phorbol-12-myristate-13-acetate (PMA) [45,46]. Following
treatment with PMA, these cells constitutively form podosomes
[47,48]. Indeed, stimulation with PMA for 3 days promoted
formation of actin-rich podosomes in most of the cells and both L-
plastin and gelsolin were enriched in these podosomes, in contrast
to CapG (Fig. 1A). We determined the intensity profiles of F-actin
and L-plastin, gelsolin or CapG along a line intersecting the whole
cell. The podosome is defined as an area that is highly enriched in
F-actin, defined here as an increased F-actin staining intensity.
The intensity profiles emphasize that gelsolin and L-plastin
coalesce with F-actin enriched structures, meaning they are
enriched in podosomes, while CapG shows a more diffuse and
distinct staining pattern (Fig. 1B).
Interestingly, the L-plastin and gelsolin expression level
increases as judged by western blotting on crude lysates of
PMA-stimulated THP-1 cells (Fig. 1C). The expression was 2.5–3
fold higher after PMA stimulation, whereas there was no
difference in CapG expression between stimulated and unstimu-
lated cells. Our data indicate that L-plastin and gelsolin are bona
fide constituents of podosomes in THP-1 cells.
Actin-bound gelsolin is enriched in podosomes whereas
LPL Nbs target actin-free L-plastin
We expressed EGFP-tagged L-plastin, gelsolin or CapG
nanobodies (Fig. 2A) in macrophage-like THP-1 cells in a stable
manner by lentiviral transduction. L-plastin nanobody 5 (LPL
Nb5) blocks the actin bundling activity by targeting a hinge region
in between the actin binding domains of L-plastin (Kd 40 nM). L-
plastin nanobody 9 (LPL Nb9) interacts with the N-terminal EF-
hands (Kd 80 nM) in a calcium-dependent manner and locks
plastin in an inactive conformation [39] (Fig. 2A). Gelsolin
nanobody 11 (GSN Nb11) prevents gelsolin-G-actin interaction
(Kd 5 nM) irrespective of the calcium concentration whereas GSN
Nb13 only recognizes calcium-activated gelsolin (Kd 10 nM) [40].
CapG Nb4 binds to the first domain of CapG (Kd 5.3 nM), but
has no inhibitory effect on F-actin or G-actin binding by CapG
(Van Impe et al., unpublished data). Immunoprecipitation
experiments confirmed the efficacy of nanobodies to pull-down
their respective antigens, following expression induction with
doxycycline (0.5 mg/ml) (Fig. 2B). Expression of LPL Nb5 and
GSN Nb11 was higher as compared to LPL Nb9 and GSN Nb13,
respectively, as observed previously in Jurkat T cells [38]. In THP-
1 cells, the LPL nanobodies interacted with L-plastin that was
completely devoid of actin as observed previously [39] whereas
GSN nanobodies bound two different gelsolin populations, in
agreement with earlier observations [40] (Fig. 2C). These findings
highlight consistent nanobody functionality in different cell types.
Actin did not co-immunoprecipitate with CapG Nb4 (Fig. 2C).
Considering their localization and biological properties, GSN
and L-plastin likely participate in dynamic actin reorganization
during podosome formation and/or disintegration but mechanistic
insights are lacking. To check whether GSN and LPL nanobodies
are targeted to podosomes and interact with their respective
antigens, we investigated their subcellular localization in THP-1
cells. Cells stably expressing EGFP or EGFP-tagged CapG Nb4
were used as negative controls and were therefore also stained for
L-plastin. Notably, GSN Nb13 was enriched in podosomes (Fig. 3)
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and the intensity profile confirmed that GSN Nb13 coincided with
the profile of actin and gelsolin (Fig. S1). For GSN Nb11, this was
not the case. These results are in agreement with immunoprecip-
itation experiments (Fig. 2C) [38,40]. LPL Nb5 and 9 were mostly
not enriched in podosomes (Fig. 3) and this is in accordance with
previous data showing that LPL Nbs recognize an actin-free
population of LPL (Nb9) or prevent actin bundling (Nb5) [38].
This is underscored by immunoprecipitation experiments (Fig. 2C).
The observed intensity profile is diffuse, contrasting with F-actin
but similar to the pattern of EGFP and CapG Nb4 (Fig. S1). We
conclude that GSN Nb13 targets calcium-activated and actin-
bound gelsolin and traces this complex in podosomes, indicating
that endogenous gelsolin is a bona fide component of podosomes in
THP-1 cells. We next investigated potential defects in podosome
function induced by nanobodies.
Gelatin degradation by THP-1 cells is impaired by LPL
nanobodies
Podosomes are thought to contribute to tissue invasion and
matrix remodeling. Invadopodia have been recognized early on as
structures that degrade matrix proteins [49] whereas for podo-
somes this was demonstrated more recently [50]. We plated cells
onto Cy3-labeled gelatin-coated coverslips for 24 hours. Matrix
degradation was observed as black areas (Fig. 4A). 30%–35% of
THP-1 cells expressing EGFP, CapG Nb4, GSN Nb11 or 13
degraded the matrix within 24 hours (Fig. 4B). For cells expressing
LPL Nb5, only 18.7% of the cells degraded the matrix. For LPL
Nb9-expressing cells, this number was further reduced to 11.9%.
Thus L-plastin is specifically involved in matrix remodeling and
LPL Nbs counteract the function of L-plastin in podosomes of
THP-1 cells whereas GSN and CapG Nbs have no such effect.
The decrease in matrix degradation efficiency for LPL Nbs
is independent of MMP production, secretion or
localization
Degradation of the extracellulair matrix by podosomes occurs
by localized secretion of specialized proteases [51]. We set out to
examine whether the low matrix degrading capacity of LPL Nb-
expressing THP-1 cells could result from altered expression,
release and/or localization of matrix-degrading proteases. Matrix
metalloproteinases (MMPs) are known to be important for matrix
degradation by podosomes and invadopodia (reviewed in [51,52]).
MMP2, MMP9 and MMP14 belong to the ‘standard equipment’
of podosomes and invadopodia [41,51] and are by consequence
the most studied representatives in macrophages and other
podosome-displaying cells. These MMPs are secreted in an
inactive (latent) form, called zymogen or pro-MMP. Latent MMPs
require activation to become active enzymes able to cleave ECM
components. MMP2 and MMP9 are gelatinases, whereas MMP14
is a membrane-type matrix metalloproteinase (MT1-MMP).
Especially MMP9 (pro-MMP9) is extensively expressed in and
secreted by macrophages [53].
To test a possible role for L-plastin in the secretion of MMPs,
we performed gelatin zymography on conditioned media of stable
THP-1 cells. The results in Fig. 4C show that MMP9, based on its
gelatinase activity and apparent molecular weight, indeed is the
most prominent protease in (THP-1) macrophages. When cells
were seeded on fibronectin-coated wells, the secretion of (pro-
)MMP2 (pro-MMP2: 72 kDa/MMP2: 64 kDa) increased slightly
(Fig. S2A), which has also been reported for dendritic cells [54]
and T lymphocytes [55]. However, secretion of (pro-)MMP9 and
(pro-)MMP2 in LPL Nb-expressing THP-1 cells was not reduced
compared to control conditions or other nanobodies (Fig. 4C and
Fig. S2A). Immunoblot analysis of the corresponding cell lysates
(Fig. 4D: MMP2 and MMP9) and media (Fig. 4E: MMP9 and Fig.
S2B: MMP2) showed that production of these MMPs was the
same for all conditions, which is in agreement with the results
shown in Fig. 4C. Again, MMP2 could only be detected in
conditioned medium when the cells had been stimulated with
fibronectin (Fig. S2B). MMP14 or MT1-MMP was also detected
in cell lysates but expression of this protease was similar for the
different nanobodies and EGFP (Fig. 4D).
Microscopic analysis of the localization of MMP2, MMP9 and
MMP14 in parental THP-1 cells confirmed that MMP9 is a highly
expressed protease (Fig. S2C). Stable macrophage-like THP-1 cells
were also stained for MMP2, MMP9 and MMP14. The
localization and expression of MMP9 (Fig. S2D), MMP2 and
MMP14 (data not shown) did not change in LPL-Nb expressing
THP-1 cells. Taken together, these results indicate that the low
degrading capacity of LPL Nb-expressing THP-1 cells is not due
to altered proteolytic activity. We also conclude that only LPL Nbs
perturb functional podosome formation while others seem to have
little or no affect at all. We therefore further examined the
underlying mechanism.
Ser5 phosphorylated L-plastin localizes to podosomes
L-plastin phosphorylation increases its F-actin bundling activity
and promotes targeting to sites of actin assembly in the cell by
switching the protein from a ‘low-activity’ to ‘high-activity’ state
[16]. We previously demonstrated the importance of LPL Ser5
phosphorylation upon CD3/CD28-activation of human T-cells
[38]. We first investigated the localization of phosphorylated L-
plastin in PMA-stimulated macrophage-like THP-1 cells using a
Ser5 phospho-L-plastin antibody [16]. A striking focal enrichment
of phosphorylated L-plastin in podosomes could be observed in
these cells (Fig. 5A). Secondly, we investigated whether phosphor-
ylation of LPL in PMA-stimulated THP-1 cells that express LPL
Nb5 or 9 is affected. Interestingly, whereas L-plastin nanobodies
delay and reduce L-plastin phosphorylation in CD3/CD28-
stimulated Jurkat T cells [38], the level of phosphorylation and
kinetics were unaffected in THP-1 cells (Fig. 5B). A drastic
increase in LPL phosphorylation was observed after 15 min with a
maximum at 30–45 min. After one hour of PMA treatment the
signal decreased. This pattern is conserved for the different stable
THP-1 cells indicating that the observed effects on matrix
remodeling is independent of the L-plastin phosphorylation status
and that L-plastin phosphorylation is dependent on the cell
context.
Figure 1. L-plastin and gelsolin localize to podosomes of THP-1 macrophages. (A) Monocytic THP-1 cells were differentiated with PMA for 3
days. Cells were stained for F-actin (phalloidin-alexa 594, red) and L-plastin, gelsolin or CapG (alexa-488, green). The pictures were acquired with a
laser scanning confocal microscope and are representative for three independent experiments. Bar: 10 mm. (B) Graph of the F-actin and LPL/CapG/
GSN intensities measured along the line, drawn across the (podosomes of the) cell. Intensity profiles were represented as function of the length (mm)
of the line. (C) Lysates of PMA-stimulated versus –unstimulated THP-1 cells were blotted and probed for L-plastin, CapG, actin or gelsolin. Blots are
representative for two independent experiments. Densitometry was used to determine band intensity in (C) and is expressed as GSN:actin, LPL:actin
and CapG:actin.
doi:10.1371/journal.pone.0078108.g001
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L-plastin nanobodies perturb podosome formation in
THP-1 cells
Close examination of THP-1 cells expressing LPL Nb5 or 9
revealed striking effects since the distinct, ‘dot-like’ appearance of
actin and cortactin, which is so typical for podosomes, disappeared
in many of the observed cells. This is shown for LPL Nb5 in
Fig. 6A (actin staining) and Fig. S3 (actin/cortactin staining). This
finding was unique to L-plastin nanobodies and could not be
observed for THP-1 cells expressing EGFP, CapG Nb4 or GSN
nanobodies, again attesting to the specificity. For LPL Nb5/9,
podosomes did not present as crisp, distinct dots, but many cells
showed a diffuse phenotype with blurry dots. We term this a
‘disrupted phenotype’ and quantified as such the number of cells
that showed ‘normal podosomes’, ‘no podosomes’ or the ‘disrupted
phenotype’ (Fig. 6B). LPL Nb5- and Nb9-expressing cells showed
significantly more cells with a disrupted phenotype (43.57% and
40.04%, respectively, compared to 620% for EGFP-, CapG Nb4-
and GSN Nb-expressing cells). The number of cells displaying
normal podosomes was significantly decreased for cells expressing
LPL Nb5 (23.42%) or LPL Nb9 (31.92%) compared to other
conditions (50–60%). There was also a significant increase in cells
that lack podosomes for LPL Nb5 (33.02%) compared to other
conditions (18–28%). Moreover, staining of LPL in the LPL Nb-
expressing cells revealed also a diffuse, ‘disrupted’ phenotype,
coinciding with the F-actin pattern (Fig. 3), or LPL being even
completely absent from podosomes (Fig. 6C). We therefore
reasoned that LPL Nbs may trigger podosome instability by
disrupting L-plastin F-actin bundling activity (Nb5) or preventing
its activation (Nb9). To verify this hypothesis we visualized and
quantified the lifetime of podosomes.
LPL Nb-expressing THP-1 cells display unstable
podosomes with a shorter lifetime
Podosomes are short-lived, with a lifetime of 2–20 minutes [56]
and characterized by fast turnover, especially in the leading
lamella of cells [57]. Moreover, their inner dynamic is even faster:
F-actin in the core turns over 2–3 times during the lifespan of a
podosome [2]. We investigated if L-plastin nanobodies affect F-
actin turnover and podosome lifetime. Stable THP-1 cells
constitutively expressing the F-actin binding peptide LifeAct-
mCherry [58] and inducibly expressing EGFP or the EGFP-
tagged nanobodies were generated for this purpose. Podosome
turnover was investigated by time-lapse imaging of cells for
20 minutes (Fig. 7A and Video S1). THP-1 cells expressing L-
plastin Nb5 and 9 did not show a regular cyclic turnover of F-actin
in podosomes. The podosomes were very unstable and short-lived,
as compared to the other conditions. A significantly larger part of
the podosomes of LPL-Nb expressing cells had a lifetime of 0–2 or
2–6 minutes (36–48%), whereas for the other conditions, only 1–
14% of the podosomes displayed such short lifespans (Fig. 7B).
GSN Nb11-expressing cells on the other hand, display more long-
lived podosomes (15–20 minutes) compared to the other condi-
tions, demonstrating a stabilizing effect of this Nb.
The instability of the podosomes of LPL Nb-expressing cells is
also apparent when the actin intensity profile is plotted over time
(Fig. 7C). Cells expressing EGFP or GSN/CapG nanobodies show
a gradual increase and decrease in actin intensity whereas the actin
intensities for cells expressing LPL Nb5 and 9 show only slight
changes. The podosomes of these cells appear and disappear in
such an irregular manner that they cannot be properly formed.
Boxplots of the variation in F-actin intensity show significant
differences between LPL Nb-expressing cells and cells expressing
EGFP or other nanobodies (Fig. 7D). We therefore conclude that
plastin nanobodies obstruct formation of new actin bundles
leading to podosome instability which results in short-lived
podosomes.
Discussion
The physiological relevance of podosomes in leukocytes has
been under considerable investigation in recent years. These
intrinsically dynamic structures modulate cellular motility, matrix
remodeling and tissue invasion [10]. Impairment of podosome
formation leads to a number of symptoms and diseases and the
role of actin binding proteins in the maintenance of these
structures is also well described (reviewed in [10,31,41,52]). In
this study we investigated the effect of nanobodies targeting three
well-known actin binding proteins on podosome formation,
dynamics and function in macrophage-like THP-1 cells. We
observed that CapG is not present in macrophage-differentiated
THP-1 podosomes. Expression of CapG Nb4, a high affinity
nanobody targeting CapG (Van Impe et al., unpublished data),
had no effect whatsoever on podosome formation and function.
This nanobody consequently served as a negative control
throughout the study.
Whereas CapG does not seem to play any major role in
podosome formation, targeting of L-plastin and gelsolin using
thoroughly characterized nanobodies demonstrated that L-plastin
not only resides in podosomes, but clearly is involved in formation
and stability of podosomes. Gelsolin Nb13 is shown here for the
first time to trace endogenous gelsolin in a distinct subcellular
structure, unlike GSN Nb11. The latter sequesters actin-free
gelsolin and perturbs actin binding in vitro while GSN Nb13
specifically targets a calcium-activated and actin-bound gelsolin
subpopulation but does not inhibit actin binding [40]. This was
again confirmed by pull-down experiments in the presence or
absence of EGTA performed in this study. Hence, the ability of
GSN Nb13 to trace endogenous, actin-bound, gelsolin in
podosomes validates our earlier in vitro findings asserting that
GSN Nb13 does not disturb any apparent function of gelsolin.
Moreover, GSN Nb13 is the only nanobody used in this study
displaying a podosome-enriched pattern. The absence of GSN
Nb11 from podosomes further attests that gelsolin is present in an
actin-bound configuration in podosomes.
Figure 2. Nbs targeting distinct structural domains of L-plastin, gelsolin and CapG, interact specifically with their target. (A) LPL
consists of two N-terminally located EF-hands (EF) and two C-terminally located ABDs. Both ABDs are divided into two calponin homology (CH)
domains. LPL Nb9 recognizes the EF-hands, whereas LPL Nb5 binds the two ABDs combined. Gelsolin consists of six homologous domains, whereas
CapG consists of 3 domains. GSN Nb11 recognizes the N-terminal part (domain 2) and GSN Nb13 binds to domains 4 and 5 combined (C-terminal
part). CapG Nb4 binds to the first domain of its target. (B) THP-1 cells expressing EGFP-tagged LPL/GSN/CapG Nbs or EGFP were generated by stable
transduction; expression of these constructs is induced by doxycycline. Cell lysates were incubated with a polyclonal EGFP antibody, followed by
binding on protein G sepharose to immunoprecipitate the EGFP-tagged Nbs or EGFP. The blots were stained for L-plastin, gelsolin or CapG and EGFP
to demonstrate the interaction between the expressed Nb and its target in the presence of doxycycline. (C) Co-immunoprecipitations experiments as
described in (B) were conducted in the absence or presence of EGTA. The blots were stained for L-plastin, gelsolin or CapG, EGFP and actin. Blots are
representative for four independent experiments. CL: crude lysate, DOX: doxycycline.
doi:10.1371/journal.pone.0078108.g002
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Preventing gelsolin-G-actin interaction (by GSN Nb11) showed
no significant effect on podosome formation or function. Earlier
studies have demonstrated gelsolin localization in podosomes
although its function in that compartment is subject to debate.
Gelsolin deficiency in mouse osteoclasts promotes loss of
podosomes and actin rings [30]. However, podosome formation
in dendritic cells appears to be gelsolin-independent. In osteoclasts,
podosomes fuse together into podosome rings or ‘belts’, constitut-
ing the sealing zone which is required for bone resorption.
Dendritic cells and macrophages generate highly dynamic
podosome clusters, changing their location as the cell changes
shape whereas the sealing zone is more static [2,32]. Ma and
coworkers suggested that sealing rings may not be derived from
podosomes which may explain in part seemingly contradictory
data [59]. Functional redundancy is a likely aspect further
contributing to the seeming lack of gelsolin involvement in
podosome formation or matrix degradation, as observed recently.
Indeed, redundancy between gelsolin and supervillin was observed
in matrix degradation in human primary macrophages [60].
However, as gelsolin mainly disrupts actin filaments through its F-
actin severing activity, its role may differ from plastin and
supervillin which both have the ability to bundle actin filaments.
Thus, gelsolin could be more involved in renewing the podosome
actin pool or actin network destabilization, facilitating actin
dynamics, whereas plastin and supervillin can be envisaged as
proteins consolidating extant actin filaments. In this respect GSN
Nb11 would act as a stabilizer of podosome structure. Life cell
imaging indeed demonstrated that the presence of GSN Nb11 in
cells, as compared to GSN Nb13 and CapG Nb4, resulted in even
more stable and long-lived features although matrix degradation
properties remained unmodified.
L-plastin is found in podosomes of human neutrophils [61],
adherent macrophages [57,62] and osteoclasts [63] (reviewed in
[42]). L-plastin has been shown to play a regulatory role in
formation of the osteoclast sealing ring [59]. At the early phase of
bone resorption, actin aggregates are formed which probably serve
as precursors for the sealing ring. They speculated that actin
aggregates are formed by L-plastin due to its actin bundling
capacity. However, L-plastin null osteoclasts demonstrated normal
osteoclast differentiation and peripheral podosomes [59].
L-plastin nanobodies were previously shown to perturb immune
synapse formation, MTOC docking, proliferation and IL-2
secretion of human T cells, and this was associated with a
significant delay in Ser5 L-plastin phosphorylation [38]. Based on
the similarities in cytoskeletal architecture between the immune
synapse and podosomes [64], we postulated that these nanobodies
could affect podosome formation. L-plastin is enriched in
podosomes of THP-1 cells and co-localizes with F-actin in these
structures. Furthermore, in cells expressing LPL Nb5/9, we were
able to discern an increased number of cells lacking podosomes
and cells displaying ‘diffuse’ podosomes (blurred phenotype).
Importantly, actin turnover in cells expressing these nanobodies
was hampered as the podosomes were unstable and short-lived,
displaying significantly shorter lifespans compared to the other
conditions. A significant decrease the matrix degrading capacity of
these cells could be observed.
Podosomes and invadopodia are specialized degrading struc-
tures, important for proteolytic cell invasion and matrix remod-
eling [10,52]. Podosomes are characterized by a high turnover and
are thought to degrade the matrix in a widespread and shallow
manner, whereas the more stable invadopodia seem to mediate a
more focused and deeper degradation [51]. Production as well as
secretion and localization of MMP2, MMP9 and MMP14, were
found to be unaffected by nanobody-mediated inhibition of L-
plastin. We propose that the defective degrading capacity of these
cells is most likely due to structural distortion and malformation of
the podosomes, resulting in diminished ECM proteolytic activity.
Similar observations have been made in macrophages deficient for
the Src family tyrosine kinase Hck. ECM degradation in these cells
is impaired, probably as a result of defective podosome rosette
formation, since MMP production and secretion are unaffected
[65]. Furthermore, MMP activity proves to be subject to
regulation itself [52]. For instance, MMP9 activation requires
PKCf [66]. Matrix stiffness also influences proteolytic activity by
invadosomes [67]. Several factors therefore seem to be important
for proteolytic activity other than mere podosome/invadosome
formation.
In leukocytes and macrophages, L-plastin is regulated by Ser5
and Ser7 phosphorylation in the headpiece domain [16,38,62,68].
L-plastin phosphorylation is triggered in response to signals
mediating immune response formation, cell migration and
proliferation, resulting in relocation of L-plastin to sites of actin
assembly [16,69]. Here we show that phosphorylated L-plastin is
enriched in podosomes where it colocalizes with F-actin, consistent
with the idea that its phosphorylation enhances F-actin binding
and bundling [16,38].
L-plastin inhibition in THP-1 cells had no effect on LPL
phosphorylation, induced by PMA. In a previous study on
immune synapse formation between human T cells and antigen
presenting cells, we noticed a delay and reduction in LPL
phosphorylation upon LPL Nb expression, elicited by CD3/CD28
stimulation [38]. Different phosphorylation stimuli probably
trigger diverse signaling pathways leading to LPL phosphorylation.
LPL phosphorylation in this study is however not responsible for
the observed disruption of podosome stability since no changes in
the level or kinetics of L-plastin phosphorylation were noticed.
Direct inhibition of F-actin bundling (LPL Nb5) or preventing
L-plastin activation (LPL Nb9) leads to drastic podosome
instability over time. Immunoprecipitation experiments in THP-
1 cells (this study) or T cells [38] confirm that LPL Nb5 and 9
target an L-plastin population that is actin-free, establishing that
these nanobodies act as potent inhibitors. In effect, an earlier study
showed complete inhibition of L-plastin activity at equimolar
ratios with the respective nanobodies [39]. These molecules very
likely perturb the equilibrium between inactive and active L-
plastin, making the latter unavailable for F-actin binding and
bundling, leading to defected podosome (core) formation in THP-
1 cells. Podosomes in macrophages are especially dynamic and
they undergo 2 overlaying cycles of stiffness, which may
correspond to actin filament turnover and bundling [70].
Apart from L-plastin, other actin bundling and cross-linking
proteins participate in podosome formation and/or matrix
degradation, including alpha-actinin [71], filamin A [72], fascin
Figure 3. L-plastin Nbs perturb podosome formation in PMA-stimulated THP-1 cells. Cells were incubated with PMA for 72 h to promote
differentiation into macrophages. Expression of EGFP-tagged LPL/CapG/GSN Nbs or EGFP was induced by 24 hr incubation with doxycycline (0.5 mg/
ml). Cells were stained for F-actin (phalloidin 670, far red, shown in grey) and L-plastin or gelsolin (alexa-594, red). EGFP and EGFP-tagged nanobodies
are shown in green. The pictures were acquired with a confocal laser scanning microscope and are representative for four independent experiments.
Bar: 10 mm.
doi:10.1371/journal.pone.0078108.g003
L-Plastin Nb-Induced Perturbation of Podosomes
PLOS ONE | www.plosone.org 8 November 2013 | Volume 8 | Issue 11 | e78108
L-Plastin Nb-Induced Perturbation of Podosomes
PLOS ONE | www.plosone.org 9 November 2013 | Volume 8 | Issue 11 | e78108
[73] and supervillin [60]. Actin bundling by fascin is required for
invadopodia formation [74]. Li and coworkers further demon-
strated that although fascin does affect the lifespan of invadopodia,
it seems not to be required for bundling of rapidly cycling actin
since the turnover rate of actin was unaffacted [74]. This points to
a possible role for L-plastin in the bundling of rapidly cycling actin
in invadopodia.
The approach used in this study was aimed at blocking discrete
biological functions of an endogenous ‘undruggable’ target without
manipulating its expression. We have demonstrated that LPL
nanobodies represent a valid and powerful tool to unsettle LPL
functionality in vivo and to highlight its role as a cementing
molecule in stabilizing podosomes in macrophage-like THP-1
cells, perturbation of which induced defects in matrix degradation.
This study and earlier reports illustrate how nanobodies can be
applied in different cellular contexts to investigate various
functions of proteins in particular cellular processes. In cytoskel-
eton studies they have proven helpful in investigating cancer cell
invasion and motility [39,40] (Van Impe et al, unpublished data)
as well as studying immunological processes [38]. Nanobodies can
be either used as ‘tracers’ with no impact on antigen functionality
and/or localization, or as direct protein inhibitors. As such they
represent an instrument of choice to mimic the activity of small
pharmacological compounds. Such molecules are difficult, albeit
not impossible [75–77] to raise against structural (non-enzymatic)
proteins, many of which play a role in the etiology or progression
of various diseases [78].
Materials and Methods
Ethics
An ethics statement is not required for this work.
Figure 4. LPL Nbs impair gelatin degradation by THP-1 cells but MMP production and secretion remain unaffected. THP-1 cells were
plated onto Cy3-labeled gelatin-coated glass coverslips for 24 hours and subjected to immunofluorescence analysis. (A) EGFP-tagged nanobodies are
depicted in green and gelatin in red. In the merged pictures, the nuclei are stained by DAPI and depicted in blue. Dark regions in the fluorescent
gelatin monolayer (red) are indicative of gelatin degradation. Bar: 30 mm. (B) Quantification of the percentage of THP-1 cells capable of degrading the
gelatin matrix. Data indicate means +/2 SEM from 3 independent experiments (n = 450–800). Unpaired t-tests were performed to observe statistical
differences in the degradation potential between cells expressing EGFP and cells expressing the nanobodies (ns: non significant p.0.05; ** p,0.01;
*** p,0.001). Stably transduced THP-1 cells (56105 cells per condition) were seeded into 12-wells in the presence of PMA for 72 h. (C) The
conditioned media of these cells were subjected to gelatin zymography. (D, E) Immunoblot analysis performed on THP-1 cell lysates (D) and
conditioned media (E) for (pro-)MMP2, (pro-)MMP9,(pro-)MMP14 (D) and (pro-)MMP9 respectively (E). In (D), actin was used as a loading control.
These data are representative of 8 independent experiments.
doi:10.1371/journal.pone.0078108.g004
Figure 5. Ser5 phosporylated L-plastin is enriched in podosomes. (A) PMA differentiated THP-1 cells were stained for phospho-Ser5 L-plastin
(alexa 488, green) and F-actin (phalloidin-alexa 594, red). Bar: 10 mm. (B) L-plastin phosphorylation is unaffected by LPL Nbs. THP-1 cells stably
expressing EGFP, GSN Nb11, LPL Nb5 and LPL Nb9 were stimulated for different periods of time with PMA. The blots were stained for phospho-L-
plastin and total L-plastin as a loading control. Data are representative of three independent experiments. Densitometry was used to determine band
intensity in (B) and is expressed as phospho-LPL:LPL.
doi:10.1371/journal.pone.0078108.g005
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Figure 6. LPL Nbs disturb podosome integrity. (A) Confocal images showing the different phenotypes, observed in THP-1 macrophages. Cells
expressing GSN Nb11 or LPL Nb5 are shown in green and cells were stained for F-actin (phalloidin-alexa 594, red). Bar: 10 mm. (B) Representation of
the observed phenotypes (‘Podosomes’, ‘No podosomes’ and ‘Disrupted phenotype’) for the different constructs. 600–1200 cells were counted per
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Reagents and antibodies
A monoclonal anti-V5 antibody was purchased from Invitrogen
(Merelbeke, Belgium); monoclonal L-plastin antibody was from
Thermo Scientific Lab Vison (Kalamazoo, MI, USA). Gelsolin
monoclonal antibody and DAPI were from Sigma-Aldrich (St.
Louis, MO, USA). Polyclonal anti-gelsolin, anti-CapG and anti-
EGFP antibodies were obtained as described [26,79]. Polyclonal
rabbit IgG against serine-5 phosphorylated L-plastin (anti-Ser5-P)
was a kind gift from dr. Evelyne Friedrich (University of
Luxembourg) and has been characterized before [16]. Rabbit
anti-EGFP antibody was purchased from Cell Signaling (Danvers,
MA, USA). Alexa Fluor 488/594-conjugated goat anti-mouse/
anti-rabbit IgGs and Alexa Fluor 594 phalloidin were obtained
from Molecular ProbesH-Life TechnologiesTM (Grand Island, NY,
USA). Acti-stainTM 670 phalloidin was from Tebu-Bio (Le Perray-
en-Yvelines, France). Rabbit monoclonal anti-MMP2, MMP9 and
MMP14 (MT1-MMP) were purchased from Epitomics (Burlin-
game, CA, USA). Rabbit polyclonal MMP2 was from Santa Cruz
Biotechnology (Dallas, Texas, USA). A cortactin monoclonal
antibody and the QCMTM Gelatin Invadopodia Assay containing
Cy3-labeled gelatin, were purchased from Millipore (Billerica,
MA, USA). Phorbol 12-myristate 13-acetate (PMA), fibronectin
and gelatin were from Sigma-Aldrich (St. Louis, MO, USA).
Doxycycline was from Clontech (Mountain View, CA, USA).
AmaxaH Cell Line NucleofectorH Kit V was obtained from Lonza
(Cologne, Germany).
Cell culture and transfection
THP-1 monocytic leukemia cells (ATCCH TIB-202TM) were
maintained at 37uC in a humidified 5% CO2 incubator and grown
in RPMI 1640 (GibcoH- Life TechnologiesTM, Grand Island, NY,
USA) supplemented with 10% fetal bovine serum, 0.1%
(0.05 mM) beta-mercaptoethanol, 100 mg/ml streptomycin and
100 IU/ml penicillin. THP-1 cells were differentiated into
adherent, macrophage-like THP-1 cells by stimulation with
350 nM PMA for 3 days.
Generation of nanobodies and cDNA cloning
L-plastin and gelsolin nanobodies were obtained in collabora-
tion with the VIB nanobody service facility and described earlier
[39,40]. The Actin-mCherry was kindly provided by dr. Klemens
Rottner (Helmholtz Centre for Infection Research, Braunschweig,
Germany).
Generation of stable THP-1 cell lines
THP-1 cells stably expressing EGFP or EGFP-tagged (LPL/
GSN/CapG) nanobodies were created using the Lenti-XTM Tet-
OnR Advanced Inducible Expression System from Clontech
(Mountain View, CA, USA). Upon transduction, 12-well plates
were coated with fibronectin, after which 500,000 cells and viral
mixture (MOI: 20) in a total amount of 1 ml were added. Cells
were then centrifuged for one hour at 1500 rpm. Nanobodies and
EGFP were cloned in the pLVX-Tight-Puro vector. Expression of
nanobodies/EGFP was induced by stimulation with 500 ng/ml
doxycycline for 24–48 h. For live cell imaging, these cells were
additionally transduced with the F-actin probe Lifeact-mCherry
[58], which was constitutively expressed. Lifeact-mCherry virus
was a kind gift from dr. Isabelle Maridonneau-Parini (Institut de
Pharmacologie et de Biologie Structurale, University of Toulouse,
France).
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblotting experiments were
performed as described before [38].
Immunostaining and microscopy
Immunostaining experiments were performed as described
before [38]. Stained cells were analyzed using a Carl Zeiss
Axiovert 200 M Apotome epifluorescence microscope or an
Olympus IX-81 laser scanning confocal microscope. The Zeiss
epifluorescence microsope is equipped with an Axiocam cooled
charge-coupled device (CCD) camera and data processing was
done with Axiovision software (Zeiss). The Olympus confocal
microscope is equipped with a motorized stage and an incubator
chamber to maintain the temperature and CO2 concentration
constant. Analysis of images, including generation of intensity
profiles, was done with Fluoview 1000 software.
Matrix degradation assay
Coverslips were coated with Cy3-labeled gelatin according to
the manufacturer’s instructions. 160,000 PMA-differentiated
macrophage-like THP-1-Nb cells were seeded onto the gelatin-
coated coverslips for 24 h at 37uC. The cells were subsequently
fixed and nuclei were stained with DAPI (0.4 mg/ml). Dark holes
in the matrix correspond to degraded gelatin; these cells were
counted as ‘degrading cells’.
Zymography
300,000–400,000 PMA-differentiated macrophage-like THP-1-
Nb cells were plated in uncoated or fibronectin-coated 12-well
plates. After 24 h, growth medium was substituted for serum-free
medium, supplemented with PMA and doxycycline. Another 24 h
later, medium was collected and boiled with non-reducing SDS-
PAGE buffer. Sample proteins were separated on 10% acrylam-
ide/0.075% gelatin gels, after which the gels were soaked in 2%
Triton X-100 for 1 h to remove the SDS and to allow protein
renaturation. The gels were rinsed once with MQ and incubated
in substrate buffer (0.05 M Tris-HCl, pH 7.5, 5 mM CaCl2,
0.02% (w/v) NaN3) at 37uC overnight. After incubation the gels
were stained with Coomassie Brilliant Blue R-250 for 20 minutes,
followed by incubation in destaining solution (20% methanol/10%
acetic acid) until proteolytic activity could be resolved.
Phosphorylation assay
THP-1-Nb cells were stimulated with 350 nM PMA for the
times indicated. Following stimulation, cells were lysed and
subjected to SDS-PAGE and western blotting.
Live cell imaging of podosome turnover
440,000 THP-1 cells, constitutively expressing LifeAct-
mCherry, were seeded in 35 mm m-dishes from Ibidi (Planegg/
Martinsried, Germany). After stimulation with PMA and doxycy-
cline, the macrophage-like THP-1-Nb-LifeAct cells were imaged
condition in 4–5 independent experiments. Error bars represent mean 6 SEM. Unpaired t-tests were performed to observe statistical differences
between cells expressing EGFP and cells expressing the nanobodies (ns: non significant p.0.05; * p,0.05). (C) THP-1 macrophages stably expressing
LPL nanobodies show a diffuse LPL staining. Cells were stained for F-actin (phalloidin 670, far red, shown in grey) and L-plastin (alexa-594, red). LPL
Nb5 is shown in green. Pictures were acquired with a confocal laser scanning microscope and are representative for four independent experiments.
Bar: 10 mm.
doi:10.1371/journal.pone.0078108.g006
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using the Olympus confocal microscope, at a constant temperature
of 37uC. In each experiment, time-lapse images of the live cells
were acquired every 20 seconds in one z plane over a period of
20 minutes, resulting in a 2D reconstruction of the actin turnover
in the podosomes. Subsequently, relative actin intensity profiles as
a function of time were generated for representative podosomes of
each condition. A line was drawn across the podosome, followed
by analysis of the intensity of the actin staining along that line
(Fluoview 1000 software: ‘line series analysis’). These intensities
were then plotted as a function of time.
Statistical analysis
Statistical analysis was performed with Unpaired Student t tests
or Mann-Whitney Rank Sum tests, when samples were normally
or not normally distributed respectively (SigmaPlot 12).
Supporting Information
Figure S1 GSN Nb13 is enriched in podosomes of PMA-
stimulated THP-1 cells. Representation of the relative GFP,
LPL or GSN and actin intensity profiles of the cells, shown in Fig. 3
of the manuscript. The intensity profiles are presented as function
of the length, measured along a line, intersecting the (podosomes
of the) cell.
(TIF)
Figure S2 Expression of LPL/GSN/CapG nanobodies
does not alter the production, secretion or localization of
MMPs. (A) Stably transduced THP-1 cells (56105 cells per
condition) were seeded into fibronectin-coated 12-wells in the
presence of PMA for 72 h. Conditioned media of these cells were
collected and subjected to gelatin zymography. (B) Immunoblot
analysis was performed on these media for (pro-)MMP2. These
data are representative of 2–3 independent experiments. (C, D)
Parental (C) and stably transduced (D) THP-1 cells were plated
onto coverslips and differentiated to macrophages by PMA. These
cells were then stained for MMP2, MMP9 or MMP14 (alexa 594,
red); L-plastin (alexa 488, green) and F-actin (phalloidin 670, far
red, shown in grey). Cells expressing EGFP-tagged nbs are shown
in green (D). The pictures were acquired with a laser scanning
confocal microscope and are representative for two independent
experiments. Bar: 10 mm.
(TIF)
Figure S3 LPL Nbs disturb podosome integrity. Confocal
images showing the different phenotypes, observed in THP-1
macrophages. Cells expressing CapG Nb4 or LPL Nb5 are shown
in green and cells were stained for cortactin (alexa 594, red) and F-
actin (phalloidin 670, far red, shown in grey). Pictures were
acquired with a confocal laser scanning microscope and are
representative for two independent experiments. Bar: 10 mm.
(TIF)
Video S1 LPL Nb-expressing macrophages are unable
to form stable podosomes. Stable THP-1 cells constitutively
expressing LifeAct-Cherry and inducibly expressing EGFP (A) or
EGFP-tagged CapG Nb4 (B), GSN Nb11/13 (C/D) or LPL Nb5/
9 (E/F), were differentiated into macrophages by adding PMA for
3 days. A 2D reconstruction of podosome turnover in cells was
acquired by time-lapse confocal imaging of live cells for
20 minutes. Actin is shown in red and EGFP or the respective
nanobodies in green. LPL-Nb THP-1 cells are characterized by a
higher podosome turnover compared to other nanobodies, or the
EGFP control. Bar: 10 mm.
(ZIP)
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